Show simple item record

dc.contributor.editorMeehan, James
dc.date.accessioned2022-05-06T11:20:48Z
dc.date.available2022-05-06T11:20:48Z
dc.date.issued2022
dc.identifierONIX_20220506_9783036539188_66
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/81000
dc.description.abstractBiomarkers are measures of a biological state. The treatment of individual patients based on particular factors, such as biomarkers, distinguishes standard, generalized treatment plans from personalized medicine. Even though personalized medicine is applicable to most branches of medicine, the field of oncology is perhaps where it is most easily employed. Cancer is a heterogeneous disease; although patients may be diagnosed histologically with the same cancer type, their tumors can comprise varying tumor microenvironments and molecular characteristics that can impact treatment response and prognosis. There has been a major drive over the past decade to try and realize personalized cancer medicine through the discovery and use of disease-specific biomarkers. This book, entitled “Cancer Biomarker Research and Personalized Medicine”, encompasses 22 publications from colleagues working on a diverse range of cancers, including prostate, breast, ovarian, head and neck, liver, gastric, bladder, colorectal, and kidney. The biomarkers assessed in these studies include genes, intracellular or secreted proteins, exosomes, DNA, RNA, miRNA, circulating tumor cells, circulating immune cells, in addition to radiomic features.
dc.languageEnglish
dc.subject.classificationbic Book Industry Communication::M Medicine
dc.subject.classificationbic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology
dc.subject.otherclear cell renal cell carcinoma
dc.subject.otherradiomics
dc.subject.otherWHO/ISUP nuclear grade
dc.subject.othermultiphasic multidetector computed tomography
dc.subject.othertriple-negative breast cancer
dc.subject.othertaxane
dc.subject.otherchemotherapy
dc.subject.otherGBP5
dc.subject.otherAkt/mTOR
dc.subject.otherautophagy
dc.subject.otherIL13Rα2
dc.subject.otherrenal cell carcinoma
dc.subject.otherJAK2
dc.subject.otherFOXO3
dc.subject.othertelmisartan
dc.subject.otherovarian cancer
dc.subject.otherbioinformatics
dc.subject.otherCREB1
dc.subject.otherdrug perturbation
dc.subject.otherlincRNA-p21
dc.subject.otherrectal cancer
dc.subject.otherchemoradiotherapy
dc.subject.othercolorectal cancer
dc.subject.otherlong non-coding RNA
dc.subject.otherp53
dc.subject.otherpredictive biomarker
dc.subject.otherintestinal anastomosis
dc.subject.otheranastomotic leak
dc.subject.otherbiomarkers
dc.subject.otherprecision medicine
dc.subject.otherpersonalized medicine
dc.subject.otherbiomarker
dc.subject.otherAmpliSeq
dc.subject.otherDNA methylation
dc.subject.otherepigenetics
dc.subject.otherhead and neck cancer
dc.subject.othersaliva
dc.subject.otherliquid biopsy
dc.subject.othermeta-analysis
dc.subject.othergastric cancer
dc.subject.othermiddle-up-down
dc.subject.otherhaptoglobin
dc.subject.otherglycopeptide
dc.subject.othermass spectrometry
dc.subject.othercirculating tumor cells
dc.subject.otherprostate cancer
dc.subject.othercancer vaccine
dc.subject.otherimmune response
dc.subject.otherbreast cancer
dc.subject.otherpredictive tools
dc.subject.otherprognostic tools
dc.subject.othertranslational research
dc.subject.otherIL6ST
dc.subject.othergp130
dc.subject.othercytokine signalling
dc.subject.othertissue-based biomarkers
dc.subject.otherliquid-based biomarkers
dc.subject.otherradiotherapy
dc.subject.otherradiosensitivity biomarkers
dc.subject.othersecretome
dc.subject.otherradioresistance
dc.subject.otherbladder tumor
dc.subject.otherlymphocyte-to-monocyte ratio
dc.subject.otherperipheral blood parameters
dc.subject.othertumor recurrence
dc.subject.othertransurethral resection
dc.subject.otherlipidomics
dc.subject.other1H-NMR
dc.subject.otherLC-MS/MS
dc.subject.otherlipoprotein subfractions
dc.subject.otherlipoprotein lipase
dc.subject.othercancer biomarkers
dc.subject.otherhepatocellular carcinoma
dc.subject.otherp16 expression
dc.subject.otherhead and neck squamous cell carcinoma
dc.subject.otherHPV genotyping
dc.subject.otherexosomes
dc.subject.otherchemoresistance
dc.subject.othercomparative oncology
dc.subject.otherOne Health
dc.subject.othermicroRNA
dc.subject.otherlymph node metastasis
dc.subject.otherhormone-dependent carcinogenesis
dc.subject.otherlocalized prostate cancer
dc.subject.otherprognostic factors
dc.subject.otherHNSCC
dc.subject.othern/a
dc.titleCancer Biomarker Research and Personalized Medicine
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-3917-1
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036539188
oapen.relation.isbn9783036539171
oapen.pages428
oapen.place.publicationBasel


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/